(Total Views: 362)
Posted On: 02/16/2021 2:14:13 PM
Post# of 145880
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
The results will be the deciding factor not personal agenda. If the primary endpoint results show a good enough benefit than CYDY gets EUA if Any of the also very important secondary end points show good benefit we will get EUA. Having EIND’s right now with a finished phase 3 trial with primary endpoint mortality 28 days along with approved OLE results would need to be clearly bad for CYDY to not get an EUA IMO.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)